Coloplast heir Louis-Hansen to chair new foundation controlling the medtech group

What's the deal? Niels Peter Louis-Hansen, heir to Danish medtech group Coloplast, has founded a new entity called the Coloplast FoundationDealroom has a profile for this one. Try Dealroom → and will serve as its chairman, the company announced on October 1, 2026. He is donating all his shares in the group to the foundation, which becomes its controlling shareholder.

How it's structured: Louis-Hansen will also chair the holding company that holds the controlling stake in Coloplast. The move consolidates control of the medtech group under the new foundation.

The leadership: Placing Louis-Hansen at the head of both the foundation and the holding company keeps the founding family at the centre of Coloplast's governance, even as ownership shifts to the foundation structure.

The signal: Foundation ownership is a well-established model in Danish business, used to anchor control and long-term stability at major companies. By transferring his stake into a foundation he chairs, Louis-Hansen follows that template to secure continuity at Coloplast.

Read more: finans.dk